2026. INVESTIGATING LONG-TERM SIDE EFFECTS OF SNRI: VENLAFAXINE, DULOXETINE, DESVENLAFAXINE, MILNACIPRAN, AND LEVOMILNACIPRAN ANTIDEPRESSANTS TREATMENT IN PATIENTS DIAGNOSED WITH DEPRESSION. International Journal of Innovative Technologies in Social Science. 2, 1(49) (Mar. 2026). DOI:https://doi.org/10.31435/ijitss.1(49).2026.4659.